Timothy Ives, Pharm.D., M.P.H., is leading one arm of a joint study between UNC, Duke, Vanderbilt and RTI International focusing on opioid de-prescribing that is funded by a $9 million grant from the Patient Centered Outcomes Research Institute. The study will … Read more

Speaker: Charlie Gersbach, Duke

A research duo from UNC Eshelman School of Pharmacy and Duke University has received a $50,000 grant to develop a new method for predicting drug safety in pediatric patients. The award is part of an effort by the neighboring Clinical … Read more

Allen Roses, MD, director of the Deane Drug Discovery Institute at the Duke University School of Medicine, will receive this year’s Award for Public Service from the Institute for Pharmacogenomics and Individualized Therapy at the University of North Carolina at … Read more